ALBANY, N.Y.--(BUSINESS WIRE)--AMRI (NASDAQ: AMRI) announced today that David C. Lathbury, Ph.D. has joined the company as vice president of chemical development reporting to Dr. Steven Hagen, vice president of pharmaceutical development and manufacturing.
